Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  US Nuclear Corp.    UCLE

US NUCLEAR CORP.

(UCLE)
  Report
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

US Air Force MACH2 Code Tests US Nuclear and MIFTI Progress Towards Goals of Producing Medical Isotopes and Electric Power

05/12/2020 | 08:31am EST

Los Angeles, CA, May 12, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- US Nuclear Corp. (OTC: UCLE) is excited about MIFTI’s (Magneto-Inertial Fusion Technologies, Inc.) recent progress in harnessing clean fusion energy as presented by a new article in a leading peer-reviewed fusion energy journal, AIP Physics of Plasmas. 

Below are some of the steps along the way towards producing clean, no-carbon fusion energy and medical isotopes:

  • August 2018: MIFTI Reaction Cell generates a record 10 billion neutrons per pulse on the 1 million ampere Zebra machine at the University of Nevada, Reno National Terawatt Facility (UNR/NTF) using their patented Staged Z-pinch (SZP) technology.

  • The US Air Force MACH-2 simulation code predicts that US Nuclear partners are likely to achieve 1 trillion neutrons per pulse or better on the L3 Harris 4 million ampere machine; the amount required for commercial production of radioisotopes and possibly to produce enough energy to achieve "Break Even" which is the gateway requirement for electric power production.

  • Year 2020: Plans are now underway to scale-up power for MIFTI and sister company, MIFTEC Laboratories, Inc. (for radiopharmaceuticals).  Experiments on L3 Harris’s more powerful 4 million ampere device are planned to begin this year.

  • It all comes together: MIFTI/MIFTEC have already drawn up the plans for their 10 million ampere machine, which is designed to provide significant net energy gain for production of power and medical isotopes.

  • MIFTI's SZP thermonuclear fusion energy technology is fueled by a simple isotope of hydrogen from seawater; an environmentally safe, low-cost process for an unlimited, non-proliferating energy source.

Thermonuclear fusion is a means to fuse atoms together using extremely high temperature and pressure.  The sun and other stars are powered by nuclear fusion energy, fusing together lighter gas atoms by compressing them under enormous gravitational force and temperatures exceeding 15 million °C.  The resulting thermal energy (heat) is contained by gravitational pressure balanced by thermal pressure.  In order to achieve thermonuclear fusion on earth, a thermonuclear reactor must achieve temperatures equal to the sun’s core while confining and constricting this reaction through a magnetic force, inertial force, or a combination of both called magneto-inertial force.  MIFTI achieves this by surrounding a lighter gas with a heavier gas and compressing it through application of a large current.

US Nuclear is an investor and strategic partner, owning 10% of MIFTEC and exclusive manufacturing and sales rights for the medical isotope generators in North America and Asia, and a smaller percentage of MIFTI.

The article can be found in Physics of Plasmas here: https://aip.scitation.org/doi/10.1063/1.5131770. 

Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at www.usnuclearcorp.com

CONTACT:

US Nuclear Corp. (OTC: UCLE)

Robert I. Goldstein, President, CEO, and Chairman

(818) 883 7043

Email: info@usnuclearcorp.com

Primary Logo


© GlobeNewswire 2020
All news about US NUCLEAR CORP.
01/21US Nuclear Corp. Discusses Potential of 2021 Projects with The Stock Day Podc..
NE
01/06US NUCLEAR CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/06US NUCLEAR : 2019 Convertible Debenture Now Fully Converted, Closed, and Flat
AQ
2020US Nuclear Corp. Discusses The Progress of Its MIFTEC Contract and Overhuff T..
NE
2020US Nuclear Corp. Announces Third Quarter 2020 Results
GL
2020US NUCLEAR : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020US NUCLEAR : and Grapheton Brain Implants to Help Immobilized Patients
AQ
2020US Nuclear and Grapheton Brain Implants to Help Immobilized Patients
GL
2020US NUCLEAR : Secures Its Position at Bioelectronics Startup Grapheton
AQ
2020US Nuclear Secures Its Position at Bioelectronics Startup Grapheton
GL
More news
Financials (USD)
Sales 2019 3,54 M - -
Net income 2019 -3,16 M - -
Net cash 2019 0,10 M - -
P/E ratio 2019 -4,28x
Yield 2019 -
Capitalization 22,9 M 22,9 M -
EV / Sales 2018 2,02x
EV / Sales 2019 3,85x
Nbr of Employees 20
Free-Float 48,4%
Chart US NUCLEAR CORP.
Duration : Period :
US Nuclear Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
NameTitle
Robert I. Goldstein Chairman, President & Chief Executive Officer
Richard Landry COO & Director-Investor Relations
Rachel Boulds Chief Financial Officer & Secretary
Michael G. Hastings Director
Dell Williamson Director
Sector and Competitors